IC
OLMA icon

Ikarian Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Ikarian Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Sell
200,000
-349,800
-64% -$4.69M 0.27% 79
2026
Q1 		$8.2M Buy
549,800
+349,800
+175% +$7.79M 0.67% 41
2025
Q4 		$5M Buy
+200,000
New +$3.56M 0.39% 63

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Ikarian Capital's OLMA Position: Q2 2026 in Review

Ikarian Capital reduced its Olema Pharmaceuticals (OLMA) stake by 36% in Q2 2026, selling an estimated $2.88M and leaving 383,281 shares worth $4.79M. The position accounts for 0.52% of the portfolio, ranked #59.

Ikarian Capital first reported a position in OLMA in Q3 2024 and has held it in 6 quarters since. The position peaked at $19M in Q4 2025. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Ikarian Capital held 383,281 shares of Olema Pharmaceuticals worth $4.79M as of Q2 2026.
  • Ikarian Capital sold 215,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $2.88M.
  • Olema Pharmaceuticals made up 0.52% of Ikarian Capital's portfolio in Q2 2026, its #59 holding.
  • Ikarian Capital first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Ikarian Capital's Olema Pharmaceuticals position peaked at $19M in Q4 2025.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.